TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
Low-dose radiotherapy offers immediate pain relief, quicker recovery, and better movement through a non-invasive procedure
The innovation leverages Mitsui Chemicals’ oxygen-permeable InnoCell cell culture plate to efficiently collect bile while reducing stress on liver cells
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
New targeted pill offers hope for adults and teens with moderate-to-severe plaque psoriasis
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
Esprit is a multicenter, randomized, placebo-controlled, double-blind study assessing the safety, pharmacodynamics, and preliminary efficacy of S-606001 as a substrate reduction therapy
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
Subscribe To Our Newsletter & Stay Updated
